Medications

Search documents
Kepler Capital Maintains a Hold Rating on GSK plc (GSK)
Yahoo Finance· 2025-09-11 16:49
GSK plc (NYSE:GSK) is one of the best growth stocks under $50 to buy now. In a report released on September 4, David Evans from Kepler Capital maintained a Hold rating on GSK plc (NYSE:GSK), setting a price target of p1,500.00. Is GSK plc (GSK) the Best Undervalued UK Stock to Buy Right Now? GSK plc (NYSE:GSK) released its fiscal Q2 2025 earnings on July 30, reporting total sales of £8.0 billion. Total operating profit for the quarter rose 33% while total EPS increased by 35%, driven by lower CCL charges ...